<?xml version="1.0" encoding="UTF-8"?>
<p>
 <xref rid="T1" ref-type="table">Table 1A</xref> summarizes the characteristics of the patients. The majority were male and of white ethnicity. The mean age (range) was 43 (19â€“81) years. A history of intravenous drug use (IVDU) was identified in 8 (22%) patients, and all of these had acute hepatitis B in 2017 and 2018 (
 <xref ref-type="supplementary-material" rid="sup1">Figure 1; Supplementary Data</xref>). Forty-two percent did not disclose HBV risk factors. More than half of patients had a psychiatric comorbidity listed in the EHR. One patient was infected with HIV before the HBV infection. Eight (22%) patients were seropositive for HCV antibody, and 5 (14%) had detectable HCV RNA at the time of acute HBV infection. About one-third of the patients had at least 1 unrelated emergency room visit within the prior 12 months. Two patients (6%) reported vaccination against HBV several years before the infection. One of them was vaccinated upon diagnosis of HIV infection. Out of the 5 patients born after 1991, when the recommendation for universal HBV child vaccination was issued, only 1 confirmed having been vaccinated.
</p>
